These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11872968)

  • 21. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia.
    Flack JM; Sowers JR
    Am J Med; 1991 Jul; 91(1A):11S-21S. PubMed ID: 1867224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men.
    Kuusisto J; Lempiäinen P; Mykkänen L; Laakso M
    Diabetes Care; 2001 Sep; 24(9):1629-33. PubMed ID: 11522711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is it advantageous to lower cholesterol in the elderly hypertensive?
    Beckett N; Nunes M; Bulpitt C
    Cardiovasc Drugs Ther; 2000 Aug; 14(4):397-405. PubMed ID: 10999646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk continuum: implications of insulin resistance and diabetes.
    Hsueh WA; Law RE
    Am J Med; 1998 Jul; 105(1A):4S-14S. PubMed ID: 9707262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men.
    Lempiäinen P; Mykkänen L; Pyörälä K; Laakso M; Kuusisto J
    Circulation; 1999 Jul; 100(2):123-8. PubMed ID: 10402440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary prevention of coronary heart disease in elderly patients.
    Hanna IR; Wenger NK
    Am Fam Physician; 2005 Jun; 71(12):2289-96. PubMed ID: 15999866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for coronary heart disease in women.
    Hennekens CH
    Cardiol Clin; 1998 Feb; 16(1):1-8. PubMed ID: 9507775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity. A deadly triad.
    Frayn KN
    Med Princ Pract; 2002; 11 Suppl 2():31-40. PubMed ID: 12444308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-lowering for prevention of coronary heart disease: what policy now?
    Ul Haq I; Ramsay LE; Pickin DM; Yeo WW; Jackson PR; Payne JN
    Clin Sci (Lond); 1996 Oct; 91(4):399-413. PubMed ID: 8983865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidemiology of impaired glucose tolerance and hypertension.
    Kannel WB; Wilson PW; Zhang TJ
    Am Heart J; 1991 Apr; 121(4 Pt 2):1268-73. PubMed ID: 2008855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of lipid disorders in the elderly.
    Playford DA; Watts GF
    Drugs Aging; 1997 Jun; 10(6):444-62. PubMed ID: 9205850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A cross-sectional study on the treatment goals of blood pressure, serum lipids and blood glucose in elderly patients with coronary heart disease].
    Zhu Y; Wang J; Bao Y; Qiao YX; Wu LZ; Li J; Li J; Hu DY
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(21):1479-85. PubMed ID: 21914285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of cardiac rehabilitation and exercise training in secondary coronary prevention in the elderly.
    Lavie CJ; Milani RV; Littman AB
    J Am Coll Cardiol; 1993 Sep; 22(3):678-83. PubMed ID: 8354798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D; Godsland IF; Wynn V
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension, hypertrophy, and the occurrence of cardiovascular disease.
    Kannel WB
    Am J Med Sci; 1991 Oct; 302(4):199-204. PubMed ID: 1833977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clustering of cardiovascular risk factors: targeting high-risk individuals.
    Genest J; Cohn JS
    Am J Cardiol; 1995 Jul; 76(2):8A-20A. PubMed ID: 7604805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.